Novavax (NVAX) Up as EMA Recommends COVID Jab for Adolescents
EMA's Committee for Medicinal Products for Human Use recommends granting marketing approval to Novavax's (NVAX) COVID-19 vaccine for use in adolescents. The stock rises 13.9%.
Zacks via Yahoo
4 days ago